University Hospital Augsburg is with about 1,750 beds one of the largest medical centers in Germany located in Augsburg. It is a teaching hospital of the Universität Augsburg and the only hospital of maximal care in Swabia. The hospital has two locations in Augsburg.

There are 1,737 beds in Klinikum Augsburg Klinik für Gefäßchirurgie.

During the past decade, Klinikum Augsburg Klinik für Gefäßchirurgie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinikum Augsburg Klinik für Gefäßchirurgie" are "Abdominal Aortic Aneurysm" (1 trials) and "Safety and Performance of the Nellix Endovascular Sealing System" (1 trials). Many other conditions were trialed in "Klinikum Augsburg Klinik für Gefäßchirurgie" in a lesser frequency.

Most popular intervention types in "Klinikum Augsburg Klinik für Gefäßchirurgie" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nellix Endovascular Aneurysm Sealing System (Nellix®-System)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Augsburg Klinik für Gefäßchirurgie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Augsburg Klinik für Gefäßchirurgie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Klinikum Augsburg Klinik für Gefäßchirurgie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Augsburg Klinik für Gefäßchirurgie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".